The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc.'s drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc , which recently agreed to acquire NPS for $5.2 billion. Natpara is designed to treat hypoparathyroidism, a condition in which the body's parathyroid gland does not secrete enough parathyroid hormone (PTH). The hormone works with vitamin D to regulate body calcium.Analysts expect the drug to generate peak annual sales of $542 million by 2019, according to Thomson Reuters data.Shire, which makes Adderall and Vyvanse for attention deficit hyperactivity disorder, is seeking to expand its position in the field of drugs for gastrointestinal disorders and rare diseases.About 180,000 people globally suffer from hypoparathyroidism, according to New Jersey-based NPS. In about 40 percent of cases, the condition cannot be controlled with the current treatment of high doses of calcium and vitamin D.
NPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company focused on delivering therapies that transform the lives of patients with rare diseases. Shares of NPSP remained unchanged at $45.64. In the past year, the shares have traded as low as $22.11 and as high as $45.89. On average, 3552090 shares of NPSP exchange hands on a given day and today's volume is recorded at 5921348.
Shire plc (Shire) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shares of SHPG traded higher by 1.06% or $2.27/share to $216.03. In the past year, the shares have traded as low as $141.66 and as high as $264.98. On average, 1182280 shares of SHPG exchange hands on a given day and today's volume is recorded at 454235.
Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI fell by 0.2% or $-0.08/share to $39.74. In the past year, the shares have traded as low as $33.21 and as high as $41.44. On average, 748460 shares of TRI exchange hands on a given day and today's volume is recorded at 909150.
Source
